16 results on '"Constant, EL"'
Search Results
2. Treatment of Schizophrenia with Risperidone in a Wolff-Parkinson-White Patient without cardiac side effects
- Author
-
Neu, Daniel, Bon, F., Goethals, P, Constant, EL, Neu, Daniel, Bon, F., Goethals, P, and Constant, EL
- Abstract
info:eu-repo/semantics/published
- Published
- 2007
3. Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls.
- Author
-
Constant EL, Adam S, Gillain B, Lambert M, Masquelier E, and Seron X
- Subjects
- Adult, Aged, Analysis of Variance, Cognition Disorders etiology, Depressive Disorder, Major complications, Educational Status, Fatigue Syndrome, Chronic complications, Female, Humans, Male, Memory physiology, Middle Aged, Motivation, Psychiatric Status Rating Scales, Psychomotor Performance physiology, Reaction Time, Suggestion, Surveys and Questionnaires, Young Adult, Cognition Disorders psychology, Depressive Disorder, Major psychology, Fatigue Syndrome, Chronic psychology
- Abstract
Object: Chronic fatigue syndrome (CFS) patients report usually cognitive complaints. They also have frequently comorbid depression that can be considered a possible explanation for their cognitive dysfunction. We evaluated the cognitive performance of patients with CFS in comparison with a control group of healthy volunteers and a group of patients with MDD., Patients and Methods: Twenty-five patients with CFS, 25 patients with major depressive disorder (MDD), and 25 healthy control subjects were given standardized tests of attention, working memory, and verbal and visual episodic memory, and were also tested for effects related to lack of effort/simulation, suggestibility, and fatigue., Results: Patients with CFS had slower phasic alertness, and also had impaired working, visual and verbal episodic memory compared to controls. They were, however, no more sensitive than the other groups to suggestibility or to fatigue induced during the cognitive session. Cognitive impairments in MDD patients were strongly associated with depression and subjective fatigue; in patients with CFS, there was a weaker correlation between cognition and depression (and no correlation with fatigue)., Conclusions: This study confirms the presence of an objective impairment in attention and memory in patients with CFS but with good mobilization of effort and without exaggerated suggestibility., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
4. Deficit in negative emotional information processing in schizophrenia: does it occur in all patients?
- Author
-
Constant EL, Lancereau J, Gillain B, Delatte B, Ferauge M, and Bruyer R
- Subjects
- Adult, Attention physiology, Choice Behavior physiology, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Pattern Recognition, Visual physiology, Photic Stimulation methods, Reaction Time physiology, Recognition, Psychology physiology, Young Adult, Mental Processes physiology, Mood Disorders etiology, Schizophrenia, Paranoid complications, Schizophrenic Psychology
- Abstract
The nature of the impairment in the processing of emotional information in schizophrenia is still being debated. Some authors reported that schizophrenia patients would show deficits in the treatment processing of negative emotional information without a negative bias, as observed in controls, when in a combined emotional situation including positive/negative information. Eighteen subjects with paranoid schizophrenia in remission with a low level of negative symptoms and 18 control subjects were exposed to 108 pairs of pictures (International Affective Picture System) depicting different emotions (N = negative, P = positive, n = neutral) from six different combinations: N/N, P/P, n/n, P/N, P/n, and N/n. The subjects responded by clicking on a right or left button in response to a negative or positive feeling toward the stimuli (forced choice task). They were also asked to classify each of the individual pictures as positive, negative, or neutral (emotion-recognition task). In this well-defined group of paranoid schizophrenia patients in remission, we observed the persistence of a negative bias when an ambiguous situation is displayed (P/N) with the absence of an impairment in negative emotional information recognition and the presence of a positive bias in the recognition of neutral stimuli, reflecting a tendency to keep arousal-provoking perceptual cues from entering into subjective awareness., (Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
5. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
- Author
-
Bauer M, Pretorius HW, Constant EL, Earley WR, Szamosi J, and Brecher M
- Subjects
- Adolescent, Adult, Aged, Antipsychotic Agents administration & dosage, Antipsychotic Agents adverse effects, Antipsychotic Agents therapeutic use, Depressive Disorder, Major diagnosis, Dibenzothiazepines administration & dosage, Dibenzothiazepines adverse effects, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Quetiapine Fumarate, Severity of Illness Index, Sexual Dysfunction, Physiological chemically induced, Sexual Dysfunction, Physiological physiopathology, Surveys and Questionnaires, Young Adult, Delayed-Action Preparations therapeutic use, Depressive Disorder, Major drug therapy, Dibenzothiazepines therapeutic use
- Abstract
Objective: This 6-week, randomized, double-blind study evaluated efficacy and safety of adjunctive extended-release (XR) quetiapine in patients with major depressive disorder (MDD) and an inadequate response to >or= 1 antidepressant., Method: Male or female patients aged 18 to 65 years with DSM-IV-TR MDD were randomly assigned to receive quetiapine XR (150 or 300 mg/day) or placebo adjunctive to continuing antidepressant. Primary endpoint was change from randomization to week 6 in Montgomery-Asberg Depression Rating Scale (MADRS) total score. Secondary variables included MADRS response (>or= 50% reduction in score from randomization) at weeks 1 and 6, MADRS remission (
- Published
- 2009
- Full Text
- View/download PDF
6. Neuropsychiatric systemic lupus erythematosus associated with neuroleptic malignant syndrome.
- Author
-
Verdoot P, Constant EL, and Seghers A
- Subjects
- Antipsychotic Agents administration & dosage, Dibenzothiazepines administration & dosage, Droperidol administration & dosage, Female, Humans, Quetiapine Fumarate, Young Adult, Antipsychotic Agents adverse effects, Dibenzothiazepines adverse effects, Droperidol adverse effects, Lupus Vasculitis, Central Nervous System drug therapy, Neuroleptic Malignant Syndrome etiology
- Published
- 2008
- Full Text
- View/download PDF
7. Pulmonary thromboembolism associated with olanzapine and risperidone.
- Author
-
Borras L, Eytan A, de Timary P, Constant EL, Huguelet P, and Hermans C
- Subjects
- Adult, Humans, Male, Olanzapine, Antipsychotic Agents adverse effects, Benzodiazepines adverse effects, Pulmonary Embolism chemically induced, Risperidone adverse effects
- Abstract
Several studies and reports suggest an increased risk of venous thromboembolism (VTE) in patients treated with conventional antipsychotic drugs, as well as with clozapine. We report the case of a 25-year-old man with early-onset schizo-affective disorder, with no identified risk factor for thromboembolism, who developed pulmonary embolism on three occasions, once shortly after initiating treatment with olanzapine and twice with risperidone. This case indicates that VTE can be associated with the use of olanzapine and risperidone, two atypical agents having similar properties and the same 5HT2 receptors antagonism, possibly implicated in this adverse event. As suggested by this observation, patients who have had one episode of VTE with antipsychotics with an affinity for 5HT2 receptors should receive neuroleptics from other classes, such as amisulpride, which does not interact with 5HT2 receptors. They should also be closely monitored to ensure early detection and prompt treatment of VTE.
- Published
- 2008
- Full Text
- View/download PDF
8. Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.
- Author
-
Koener B, Hermans E, Maloteaux JM, Jean-Jean A, and Constant EL
- Subjects
- Antipsychotic Agents pharmacology, Aripiprazole, Bipolar Disorder metabolism, Bipolar Disorder psychology, Dopamine D2 Receptor Antagonists, Female, Humans, Middle Aged, Piperazines pharmacology, Piperazines therapeutic use, Quinolones pharmacology, Quinolones therapeutic use, Receptors, Dopamine D2 agonists, Receptors, Dopamine D2 drug effects, Antipsychotic Agents adverse effects, Antipsychotic Agents therapeutic use, Bipolar Disorder drug therapy, Parkinsonian Disorders chemically induced, Piperazines adverse effects, Quinolones adverse effects
- Published
- 2007
- Full Text
- View/download PDF
9. Absence of cardiac side effects during treatment of schizophrenia with risperidone in a patient with wolff-Parkinson-white syndrome.
- Author
-
Bon F, Constant EL, Goethals P, and Neu D
- Published
- 2007
- Full Text
- View/download PDF
10. Aripiprazole is effective in the treatment of Tourette's disorder.
- Author
-
Constant EL, Borras L, and Seghers A
- Subjects
- Adult, Aripiprazole, Female, Humans, Psychiatric Status Rating Scales, Tourette Syndrome psychology, Antipsychotic Agents therapeutic use, Piperazines therapeutic use, Quinolones therapeutic use, Tourette Syndrome drug therapy
- Published
- 2006
- Full Text
- View/download PDF
11. Successful treatment of alcohol withdrawal with trazodone.
- Author
-
Borras L, de Timary P, Constant EL, Huguelet P, and Eytan A
- Subjects
- Adult, Alcoholism complications, Alcoholism psychology, Humans, Male, Alcoholism rehabilitation, Antidepressive Agents, Second-Generation therapeutic use, Central Nervous System Depressants adverse effects, Ethanol adverse effects, Substance Withdrawal Syndrome drug therapy, Trazodone therapeutic use
- Abstract
Trazodone, a second generation antidepressant, is helpful in the treatment of lasting alcohol withdrawal symptoms, such as sleep disturbances and craving. We report a case suggesting that trazodone is also efficient for the treatment of the acute phase of alcohol withdrawal treatment. A 30-year-old male patient with severe alcohol withdrawal symptoms was successfully treated with an adjuvant administration of 600 mg trazodone per day, while he had remained symptomatic for several days under high doses of diazepam and clomethiazolum. Controlled trials with trazodone for this indication could be useful.
- Published
- 2006
- Full Text
- View/download PDF
12. Hypothyroidism and major depression: a common executive dysfunction?
- Author
-
Constant EL, Adam S, Seron X, Bruyer R, Seghers A, and Daumerie C
- Subjects
- Adult, Affective Symptoms diagnosis, Affective Symptoms etiology, Affective Symptoms physiopathology, Aged, Analysis of Variance, Anxiety diagnosis, Anxiety etiology, Anxiety physiopathology, Cognition Disorders etiology, Cognition Disorders physiopathology, Color Perception physiology, Depressive Disorder, Major physiopathology, Emotions physiology, Female, Field Dependence-Independence, Humans, Hypothyroidism physiopathology, Language Tests, Male, Middle Aged, Neuropsychological Tests, Pattern Recognition, Visual physiology, Reference Values, Severity of Illness Index, Verbal Behavior physiology, Attention physiology, Cognition Disorders diagnosis, Depressive Disorder, Major complications, Hypothyroidism complications, Perceptual Masking physiology, Psychomotor Performance physiology
- Abstract
Little is known about the possible link between the cognitive disorders associated with hypothyroidism and those encountered in depression. This study examines attentional and executive functions as well as the intensity of anxiety and depressive symptoms in hypothyroidism and major depression and the possible link between these symptoms and cognitive disturbances. This study confirms the existence of psychomotor slowing associated with attentional and executive disturbance in major depression as well as in hypothyroidism. However, while depressed subjects manifested a conscious bias with material of negative emotional valence, no such bias was found in the hypothyroid subjects. While the hypothyroid state is accompanied by anxiety/depressive symptoms, it seems that the latter are too discrete for an attentional bias to be observed with material with a negative emotional valence.
- Published
- 2006
- Full Text
- View/download PDF
13. Hypertension and aripiprazole.
- Author
-
Borras L, Constant EL, Eytan A, and Huguelet P
- Subjects
- Antipsychotic Agents therapeutic use, Aripiprazole, Female, Humans, Middle Aged, Piperazines therapeutic use, Quinolones therapeutic use, Schizophrenia, Paranoid drug therapy, Schizophrenia, Paranoid psychology, Antipsychotic Agents adverse effects, Hypertension chemically induced, Piperazines adverse effects, Quinolones adverse effects
- Published
- 2005
- Full Text
- View/download PDF
14. Anxiety and depression, attention, and executive functions in hypothyroidism.
- Author
-
Constant EL, Adam S, Seron X, Bruyer R, Seghers A, and Daumerie C
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Thyroid Function Tests, Treatment Outcome, Anxiety psychology, Attention physiology, Depression psychology, Hypothyroidism psychology, Psychomotor Performance physiology
- Abstract
Background: Divergences in cognitive disturbances in hypothyroidism reported in the literature are a result of a methodological bias., Methods: By using a precise methodology, we examined attention and executive functions in hypothyroidism, verified the presence of anxiety and depressive symptoms in hypothyroidism, and examined the possible link between these symptoms and the cognitive disturbances (searching for attentional bias for words with a negative emotional valence). We administered a battery of cognitive tests to 23 participants who had undergone thyroidectomy for thyroid carcinoma: for the first time in an euthyroid state, then 3 weeks later (still in the euthyroid state) to assess the test/retest effect, and finally 4 weeks later in an hypothyroid state. We compared their performance with that of a group of 26 control participants who were also administered the same cognitive tests, also 3 times., Results: In hypothyroidism, the thyroid participants were more anxious and depressed than the controls and presented attentional and executive disturbances that reflected general slowing and difficulties in using their capacities of inhibition. However, they did not exhibit an attentional bias for words with a negative emotional valence., Conclusions: Contrary to what was expected, symptoms of anxiety and not symptoms of depression interfered with the cognitive performance of participants in hypothyroidism.
- Published
- 2005
- Full Text
- View/download PDF
15. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression.
- Author
-
Constant EL, Adam S, Gillain B, Seron X, Bruyer R, and Seghers A
- Subjects
- Adult, Aged, Depressive Disorder, Major diagnosis, Diagnostic and Statistical Manual of Mental Disorders, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Psychomotor Performance drug effects, Reaction Time drug effects, Surveys and Questionnaires, Thyroid Function Tests, Attention drug effects, Cognition Disorders diagnosis, Cognition Disorders etiology, Depressive Disorder, Major drug therapy, Depressive Disorder, Major psychology, Selective Serotonin Reuptake Inhibitors pharmacology, Selective Serotonin Reuptake Inhibitors therapeutic use, Sertraline pharmacology, Sertraline therapeutic use
- Abstract
Reports on the severity and reversibility of cognitive disturbances in major depression in the literature diverge due to methodological biases. The present study, using a precise methodology, examined attention and executive functions in 20 relatively young, depressed patients presenting a first or second episode of unipolar major depression without psychotic or melancholic characteristics and all being treated with the same psychopharmacological treatment (sertraline) to investigate the changes in potential attentional and executive loss during a subacute period of treatment of 7 weeks. We compared their performance with a group of 26 control subjects who were administered the same cognitive tests. This study confirmed psychomotor slowing associated with attentional and executive disturbance in adults with major depression. Conscious attentional interference for words with a negative emotional valence also was shown. After the first weeks of treatment, the effect of the antidepressant treatment with sertraline was accompanied by a beneficial effect on psychomotor slowing on attentional and executive functions., ((c) 2005 Wiley-Liss, Inc.)
- Published
- 2005
- Full Text
- View/download PDF
16. Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study.
- Author
-
Constant EL, de Volder AG, Ivanoiu A, Bol A, Labar D, Seghers A, Cosnard G, Melin J, and Daumerie C
- Subjects
- Adult, Aged, Blood Glucose metabolism, Brain diagnostic imaging, Female, Humans, Hypothyroidism diagnostic imaging, Iodine Radioisotopes pharmacokinetics, Magnetic Resonance Imaging, Male, Middle Aged, Radiopharmaceuticals pharmacokinetics, Regional Blood Flow, Thyroid Neoplasms surgery, Thyroidectomy, Thyrotropin blood, Thyroxine blood, Tomography, Emission-Computed, Brain blood supply, Brain metabolism, Cerebrovascular Circulation, Fluorodeoxyglucose F18 pharmacokinetics, Glucose metabolism, Hypothyroidism metabolism, Hypothyroidism physiopathology
- Abstract
Hypothyroidism is often associated with defective memory, psychomotor slowing, and depression. However, the relationship between thyroid status and cognitive or psychiatric disturbances remains unclear. Using psychometric scales, 10 patients who had undergone total thyroidectomy for thyroid carcinoma were evaluated for depression, anxiety, and psychomotor slowing; they were examined both when euthyroid and hypothyroid after thyroid hormone withdrawal. Positron emission tomography was used, with oxygen-15-labeled water and fluorine-18F-labeled 2-deoxy-2fluoro-D-glucose as the tracers, to correlate the regional cerebral blood flow and cerebral glucose metabolism with the mental state in patients. Two different image analysis techniques (regions of interest and statistical parametric maps) were applied. In hypothyroidism, there was a generalized decrease in regional cerebral blood flow (23.4%, P < 0.001) and in cerebral glucose metabolism (12.1%, P < 0.001) and there were no specific local defects. Patients were also significantly more depressed (P < 0.001), anxious (P < 0.001) and psychomotor slowed (P < 0.005) in hypo than in euthyroid status. These results indicate that the brain activity was globally reduced in severe hypothyroidism of short duration without the regional modifications usually observed in primary depression.
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.